Fusion UltraSound Imaging Of the Thyroid GlaNd With I-124 PET. Evaluation of Nodule Allocation.

I-124 PET/US for Benign Thyroid Diseases - Blinded, Multicentric Assessment of Augmented Thyroid Work-up Versus Regular Thyroid Diagnostics

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03128255

Acronym

FUSION iENA

Enrollment

Registered

2017-04-25

Start date

2017-04-26

Completion date

2018-04-30

Last updated

2017-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Diseases, Thyroid Goitre, Thyroid Nodule

Keywords

Fusion, Hybrid Imaging, Mapping, Iodine, Ultrasound

Brief summary

Regular thyroid diagnostics versus augmented thyroid work-up with additional I-124 PET/US fusion for metabolic-sonographic nodule allocation in patients with benign thyroid diseases

Interventions

OTHERAssessment of already preacquired I-124 PET/US

Assessment of preacquired I-124 PET/US by review of anonymous digital case files

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients with thyroidal nodules, * euthyroidism * Uptake \>0,5% on Tc-99m-pertechnetate- scintigraphy

Exclusion criteria

* thyroid medications in the last 6 months * Iodine exposition in the last 6 months * thyroid surgery or radioiodine therapy

Design outcomes

Primary

Measure	Time frame	Description
Metabolic-sonographic nodule allocation	1 year	The number of correct assignments of metabolic function of each nodule will be assessed for each group seperately. A three-point scale will be used for evaluation of the nodule's function and the degree of the physicians certainty will be investigated using a four-point scale.

Countries

Germany

Contacts

Primary ContactMartin Freesmeyer, Dr.med.

martin.freesmeyer@med.uni-jena.de+49 3641 9-329805

Backup ContactChristian Hollenbach

christian.hollenbach@med.uni-jena.de+49 3641 9-329805

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026